4//SEC Filing
Darvish Nissim 4
Accession 0001551986-20-000205
CIK 0001551986other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:24 PM ET
Size
8.0 KB
Accession
0001551986-20-000205
Insider Transaction Report
Form 4
Darvish Nissim
Director10% Owner
Transactions
- Conversion
Series A Convertible Preferred Stock
2020-06-30−67,865→ 0 total(indirect: See Footnote)From: 2020-05-04→ Common stock (6,786,500 underlying) - Conversion
Common stock
2020-06-30+6,786,500→ 23,773,021 total(indirect: See footnote 1)
Footnotes (2)
- [F1]The Reporting Person is the designated representative of OrbiMed Israel GP Ltd. on the Issuer's Board of Directors. The reportable securities are owned directly by OrbiMed Israel Partners Limited Partnership ("OIP"). OrbiMed Israel BioFund GP Limited Partnership ("OrbiMed BioFund") is the general partner of OIP, and OrbiMed Israel GP Ltd. ("OrbiMed Israel") is the general partner of OrbiMed BioFund. The Reporting Person disclaims beneficial ownership of the securities reported herein for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any.
- [F2]The Series A Convertible Preferred Stock automatically converted to common stock on a 1-to-100 basis upon approval by the Company's stockholders on June 30, 2020.
Documents
Issuer
9 METERS BIOPHARMA, INC.
CIK 0001551986
Entity typeother
Related Parties
1- filerCIK 0001793602
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:24 PM ET
- Size
- 8.0 KB